Optimizing Immune Checkpoint Inhibitor/Targeted Therapy Combination Adverse Event Management

Get personalized guidance on managing immune-related AEs for your patients with our newly updated Interactive Decision Support Tool adapted from the latest NCCN guidelines. Then, gain multidisciplinary insights into managing toxicities from ICI/targeted therapy combination regimens with an expert text module and downloadable slides.

Share

Program Content

Activities

AEs With ICI/Targeted Tx
Expert Strategies for Managing Adverse Events With Combination Immune Checkpoint Inhibitor/Targeted Therapy
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: May 25, 2023

Expires: May 24, 2024

Activities

AEs With Combo ICI Tx
Managing Adverse Events With Combination Immune Checkpoint Inhibitor/Targeted Therapy
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 19, 2023

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by educational grants from AstraZeneca, Eisai, Merck Sharp & Dohme LLC, and Regeneron Pharmaceuticals, Inc.

AstraZeneca

Eisai

Merck Sharp & Dohme, LLC

Regeneron Pharmaceuticals, Inc